The FDA Approves IDE for ReGelTec's Pivotal Study HYDRAFIL for Chronic Low Back Pain

The FDA Approves IDE for ReGelTec's Pivotal Study HYDRAFIL for Chronic Low Back Pain due to Degenerative Disc Disease. ReGelTec, Inc. September 28 …
Source: back pain